The Latin America, Middle East and Africa Medical Thawing System Market is expected to witness market growth of 11.5% CAGR during the forecast period (2020-2026).
The increasing number of surgeries and growing rates of hemorrhage-related conditions in these surgeries are boosting the growth of the medical thawing system. The demand for thawed blood to be more rapidly available for hemorrhage in different invasive surgeries has been rising. Besides, this factor is also a significant contributor to the growth of the market. Furthermore, the growing number of items launches and constant development in the features of the thawing system is also adding to the demand.
The demand for medical thawing systems in labs and blood banks has been rising, where it needs warming of items like complete blood, crystalloid infusion solution, and RBC before transfusion into a patient, is anticipated to boost the development of the market. Advances in technology in automated thawing systems at the point of care settings and growing demand for past thawing methods of frozen plasma in different surgical methods are the elements pushing the growth of this market. Also, the increasing use of thawed cells because of the high road accident rates, cancer, diabetes, and trauma cases are also some of the factors that boost the demand for the medical thawing system.
Based on Product Type, the market is segmented into Manual and Automated. Based on Sample Type, the market is segmented into Blood, Ovum, Semen, Embryo and Others. Based on End Use, the market is segmented into Blood Bank & Transfusion centers, Hospitals, Tissue Banks, Biotechnology & Pharma and Other End Uses. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
By Sample Type
By End Use
By Country
Companies Profiled
Unique Offerings
The increasing number of surgeries and growing rates of hemorrhage-related conditions in these surgeries are boosting the growth of the medical thawing system. The demand for thawed blood to be more rapidly available for hemorrhage in different invasive surgeries has been rising. Besides, this factor is also a significant contributor to the growth of the market. Furthermore, the growing number of items launches and constant development in the features of the thawing system is also adding to the demand.
The demand for medical thawing systems in labs and blood banks has been rising, where it needs warming of items like complete blood, crystalloid infusion solution, and RBC before transfusion into a patient, is anticipated to boost the development of the market. Advances in technology in automated thawing systems at the point of care settings and growing demand for past thawing methods of frozen plasma in different surgical methods are the elements pushing the growth of this market. Also, the increasing use of thawed cells because of the high road accident rates, cancer, diabetes, and trauma cases are also some of the factors that boost the demand for the medical thawing system.
Based on Product Type, the market is segmented into Manual and Automated. Based on Sample Type, the market is segmented into Blood, Ovum, Semen, Embryo and Others. Based on End Use, the market is segmented into Blood Bank & Transfusion centers, Hospitals, Tissue Banks, Biotechnology & Pharma and Other End Uses. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Manual
- Automated
By Sample Type
- Blood
- Ovum
- Semen
- Embryo
- Others
By End Use
- Blood Bank & Transfusion centers
- Hospitals
- Tissue Banks
- Biotechnology & Pharma
- Other End Uses
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- General Electric (GE) Co. (GE Healthcare)
- Thermo Fisher Scientific, Inc.
- Cardinal Health, Inc.
- Helmer Scientific, Inc.
- Sarstedt AG & Company
- Boekel Scientific, Inc.
- Barkey GmbH & Co. KG
- BioCision LLC
- Sartorius AG
- CytoTherm LP
Unique Offerings
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Medical Thawing System Market by End Use
Chapter 5. LAMEA Medical Thawing System Market by Sample Type
Chapter 6. LAMEA Medical Thawing System Market by Product Type
Chapter 7. LAMEA Medical Thawing System Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Thermo Fisher Scientific, Inc.
- Cardinal Health, Inc.
- Helmer Scientific, Inc.
- Sarstedt AG & Company
- Boekel Scientific, Inc.
- Barkey GmbH & Co. KG
- BioCision LLC
- Sartorius AG
- CytoTherm LP
Methodology
LOADING...
